Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Yung Ki | - |
dc.contributor.author | Yi, Hyeong Joong | - |
dc.contributor.author | Choi, Kyu Sun | - |
dc.contributor.author | Lee, Young Jun | - |
dc.contributor.author | Kim, Dong Won | - |
dc.contributor.author | Kwon, Sae Min | - |
dc.date.accessioned | 2022-07-10T20:57:17Z | - |
dc.date.available | 2022-07-10T20:57:17Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2018-12 | - |
dc.identifier.issn | 0741-238X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/148836 | - |
dc.description.abstract | Introduction Cerebrolysin is a neuroprotective drug used in the treatment of acute ischemic stroke. To our knowledge, this drug has never been evaluated in patients with aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to evaluate the effect of Cerebrolysin in patients with aneurysmal SAH. Methods Aneurysmal SAH patients who had their aneurysm obliterated at our institution from 2007 to 2016 were retrospectively studied. Patients received Cerebrolysin treatment or standard care only (control group). Subgroup analyses were performed according to Hunt and Hess grade (good grade ≤ 2, N = 216; poor grade ≥ 3, N = 246) and treatment procedure (clip or coil). Results In good-grade patients (N = 216), clinical outcomes and mortality did not differ significantly between the control and Cerebrolysin groups. In poor-grade patients (N = 246), the mortality rate was significantly lower in the Cerebrolysin group (8.7%) than in the control group (25.4%, p = 0.006). In patients who received microsurgical clipping (N = 328), the mortality rate was significantly lower in the Cerebrolysin group (7.3%) than in the control group (18.5%, p = 0.016). Conclusion Cerebrolysin injection during the acute period of SAH appeared to reduce the mortality rate, especially in poor-grade patients. This study suggests the potential of Cerebrolysin for treating aneurysmal SAH. Further studies are needed to confirm our results. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.title | Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yi, Hyeong Joong | - |
dc.contributor.affiliatedAuthor | Choi, Kyu Sun | - |
dc.contributor.affiliatedAuthor | Lee, Young Jun | - |
dc.contributor.affiliatedAuthor | Kim, Dong Won | - |
dc.identifier.doi | 10.1007/s12325-018-0832-8 | - |
dc.identifier.scopusid | 2-s2.0-85056313781 | - |
dc.identifier.wosid | 000450985100010 | - |
dc.identifier.bibliographicCitation | ADVANCES IN THERAPY, v.35, no.12, pp.2224 - 2235 | - |
dc.relation.isPartOf | ADVANCES IN THERAPY | - |
dc.citation.title | ADVANCES IN THERAPY | - |
dc.citation.volume | 35 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 2224 | - |
dc.citation.endPage | 2235 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | TRAUMATIC BRAIN-INJURY | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | NEUROTROPHIC TREATMENT | - |
dc.subject.keywordPlus | ISCHEMIC-STROKE | - |
dc.subject.keywordPlus | RECOVERY | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | SAFETY | - |
dc.subject.keywordPlus | REPAIR | - |
dc.subject.keywordPlus | BLOOD | - |
dc.subject.keywordPlus | CARS | - |
dc.subject.keywordAuthor | Aneurysmal subarachnoid hemorrhage | - |
dc.subject.keywordAuthor | Brain hemorrhage | - |
dc.subject.keywordAuthor | Cerebrolysin | - |
dc.subject.keywordAuthor | Cerebrovascular disorders | - |
dc.subject.keywordAuthor | Neuroprotective agents | - |
dc.subject.keywordAuthor | Mortality | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs12325-018-0832-8 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.